Virology Testing Market Size, Share, and Outlook, H2-2025 Report- By Type (Instruments, Assay Kits and Consumables), By Diagnostic Technique (Molecular Diagnostics Method, Immunoassay-based Method, Mass Spectroscopy-based Method, Others), By End-User (Hos
Description
Virology Testing Market Outlook
The global Virology Testing Market Size is valued at $221.3 Million in 2025 and is forecast to reach $396.8 Million in 2032 at a CAGR of 8.7%.
The Virology Testing Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Virology Testing Market segments across 22 countries from 2021 to 2032. Key segments covered include By Type (Instruments, Assay Kits and Consumables), By Diagnostic Technique (Molecular Diagnostics Method, Immunoassay-based Method, Mass Spectroscopy-based Method, Others), By End-User (Hospitals and Clinics, Diagnostic Laboratories, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Virology Testing Market Insights, 2025
The virology testing market in 2025 continues to evolve as infectious diseases remain a global healthcare priority. Virology testing encompasses diagnostics for viral infections, viral load monitoring, and serological surveillance across clinical, research, and public health settings. While molecular diagnostics such as PCR dominate, next-generation sequencing is gaining ground for comprehensive viral genome analysis and outbreak tracing. Point-of-care platforms are also becoming more prominent, providing rapid viral detection in decentralized settings. Beyond human health, virology testing is critical in veterinary medicine, agriculture, and biopharmaceutical safety testing. The lessons from past pandemics have heightened global surveillance systems, driving demand for scalable and accurate testing platforms. Public health programs are increasingly integrating multiplex assays that can simultaneously detect multiple viral pathogens. As viral threats remain unpredictable, the virology testing market plays a central role in disease preparedness, vaccine development, and epidemiological monitoring.
Five Trends Shaping the Global Virology Testing Market in 2025 and Beyond
The global Virology Testing Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Virology Testing Industry?
The Virology Testing Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Virology Testing Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Virology Testing Market Segment Insights
The Virology Testing Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Type (Instruments, Assay Kits and Consumables), By Diagnostic Technique (Molecular Diagnostics Method, Immunoassay-based Method, Mass Spectroscopy-based Method, Others), By End-User (Hospitals and Clinics, Diagnostic Laboratories, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Virology Testing Industry Value Chain
The chapter identifies potential companies and their operations across the global Virology Testing Industry ecosystem. It assists decision-makers in evaluating global Virology Testing Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Virology Testing Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Virology Testing Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Virology Testing Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Virology Testing Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Virology Testing Market.
Europe Virology Testing Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Virology Testing Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Virology Testing Industry competitiveness. The report analyses the key Virology Testing Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Virology Testing Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Virology Testing Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Virology Testing Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Virology Testing Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Virology Testing Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Virology Testing Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, bioMérieux SA, Bi-Rad Laboratories Inc, Cepheid, DiaSorin S.p.A., F. Hoffmann-La Roche AG, Fujirebio Diagnostics Inc, Hologic Inc, QIAGEN N.V., Siemens Healthineers AG, Thermo Fisher Scientific Inc, Trinity Biotech plc, Vircell S.L.. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Virology Testing Market Scope
Leading Segments
By Type
Instruments
Assay Kits and Consumables
By Diagnostic Technique
Molecular Diagnostics MethodPCR-based methods NGS-based methods
Immunoassay-based Method
Mass Spectroscopy-based Method
Others
By End-User
Hospitals and Clinics
Diagnostic Laboratories
Others
Leading Companies
Abbott Laboratories
bioMérieux SA
Bi-Rad Laboratories Inc
Cepheid
DiaSorin S.p.A.
F. Hoffmann-La Roche AG
Fujirebio Diagnostics Inc
Hologic Inc
QIAGEN N.V.
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Trinity Biotech plc
Vircell S.L.
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Virology Testing Market Size is valued at $221.3 Million in 2025 and is forecast to reach $396.8 Million in 2032 at a CAGR of 8.7%.
The Virology Testing Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Virology Testing Market segments across 22 countries from 2021 to 2032. Key segments covered include By Type (Instruments, Assay Kits and Consumables), By Diagnostic Technique (Molecular Diagnostics Method, Immunoassay-based Method, Mass Spectroscopy-based Method, Others), By End-User (Hospitals and Clinics, Diagnostic Laboratories, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Virology Testing Market Insights, 2025
The virology testing market in 2025 continues to evolve as infectious diseases remain a global healthcare priority. Virology testing encompasses diagnostics for viral infections, viral load monitoring, and serological surveillance across clinical, research, and public health settings. While molecular diagnostics such as PCR dominate, next-generation sequencing is gaining ground for comprehensive viral genome analysis and outbreak tracing. Point-of-care platforms are also becoming more prominent, providing rapid viral detection in decentralized settings. Beyond human health, virology testing is critical in veterinary medicine, agriculture, and biopharmaceutical safety testing. The lessons from past pandemics have heightened global surveillance systems, driving demand for scalable and accurate testing platforms. Public health programs are increasingly integrating multiplex assays that can simultaneously detect multiple viral pathogens. As viral threats remain unpredictable, the virology testing market plays a central role in disease preparedness, vaccine development, and epidemiological monitoring.
Five Trends Shaping the Global Virology Testing Market in 2025 and Beyond
The global Virology Testing Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Virology Testing Industry?
The Virology Testing Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Virology Testing Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Virology Testing Market Segment Insights
The Virology Testing Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Type (Instruments, Assay Kits and Consumables), By Diagnostic Technique (Molecular Diagnostics Method, Immunoassay-based Method, Mass Spectroscopy-based Method, Others), By End-User (Hospitals and Clinics, Diagnostic Laboratories, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Virology Testing Industry Value Chain
The chapter identifies potential companies and their operations across the global Virology Testing Industry ecosystem. It assists decision-makers in evaluating global Virology Testing Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Virology Testing Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Virology Testing Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Virology Testing Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Virology Testing Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Virology Testing Market.
Europe Virology Testing Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Virology Testing Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Virology Testing Industry competitiveness. The report analyses the key Virology Testing Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Virology Testing Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Virology Testing Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Virology Testing Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Virology Testing Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Virology Testing Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Virology Testing Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, bioMérieux SA, Bi-Rad Laboratories Inc, Cepheid, DiaSorin S.p.A., F. Hoffmann-La Roche AG, Fujirebio Diagnostics Inc, Hologic Inc, QIAGEN N.V., Siemens Healthineers AG, Thermo Fisher Scientific Inc, Trinity Biotech plc, Vircell S.L.. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Virology Testing Market Scope
Leading Segments
By Type
Instruments
Assay Kits and Consumables
By Diagnostic Technique
Molecular Diagnostics Method
Immunoassay-based Method
Mass Spectroscopy-based Method
Others
By End-User
Hospitals and Clinics
Diagnostic Laboratories
Others
Leading Companies
Abbott Laboratories
bioMérieux SA
Bi-Rad Laboratories Inc
Cepheid
DiaSorin S.p.A.
F. Hoffmann-La Roche AG
Fujirebio Diagnostics Inc
Hologic Inc
QIAGEN N.V.
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Trinity Biotech plc
Vircell S.L.
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
194 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Virology Testing Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Virology Testing Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Virology Testing Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Virology Testing Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Virology Testing Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Type
- Instruments
- Assay Kits and Consumables
- By Diagnostic Technique
- Molecular Diagnostics Method
- -PCR-based methods
- -NGS-based methods
- Immunoassay-based Method
- Mass Spectroscopy-based Method
- Others
- By End-User
- Hospitals and Clinics
- Diagnostic Laboratories
- Others
- 6. Global Virology Testing Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Virology Testing Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Virology Testing Market Trends and Growth Opportunities
- 6.2.1 North America Virology Testing Market Outlook by Type
- 6.2.2 North America Virology Testing Market Outlook by Application
- 6.3 North America Virology Testing Market Outlook by Country
- 6.3.1 The US Virology Testing Market Outlook, 2021- 2032
- 6.3.2 Canada Virology Testing Market Outlook, 2021- 2032
- 6.3.3 Mexico Virology Testing Market Outlook, 2021- 2032
- 7. Europe Virology Testing Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Virology Testing Market Trends and Growth Opportunities
- 7.2.1 Europe Virology Testing Market Outlook by Type
- 7.2.2 Europe Virology Testing Market Outlook by Application
- 7.3 Europe Virology Testing Market Outlook by Country
- 7.3.2 Germany Virology Testing Market Outlook, 2021- 2032
- 7.3.3 France Virology Testing Market Outlook, 2021- 2032
- 7.3.4 The UK Virology Testing Market Outlook, 2021- 2032
- 7.3.5 Spain Virology Testing Market Outlook, 2021- 2032
- 7.3.6 Italy Virology Testing Market Outlook, 2021- 2032
- 7.3.7 Russia Virology Testing Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Virology Testing Market Outlook, 2021- 2032
- 8. Asia Pacific Virology Testing Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Virology Testing Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Virology Testing Market Outlook by Type
- 8.2.2 Asia Pacific Virology Testing Market Outlook by Application
- 8.3 Asia Pacific Virology Testing Market Outlook by Country
- 8.3.1 China Virology Testing Market Outlook, 2021- 2032
- 8.3.2 India Virology Testing Market Outlook, 2021- 2032
- 8.3.3 Japan Virology Testing Market Outlook, 2021- 2032
- 8.3.4 South Korea Virology Testing Market Outlook, 2021- 2032
- 8.3.5 Australia Virology Testing Market Outlook, 2021- 2032
- 8.3.6 South East Asia Virology Testing Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Virology Testing Market Outlook, 2021- 2032
- 9. South America Virology Testing Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Virology Testing Market Trends and Growth Opportunities
- 9.2.1 South America Virology Testing Market Outlook by Type
- 9.2.2 South America Virology Testing Market Outlook by Application
- 9.3 South America Virology Testing Market Outlook by Country
- 9.3.1 Brazil Virology Testing Market Outlook, 2021- 2032
- 9.3.2 Argentina Virology Testing Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Virology Testing Market Outlook, 2021- 2032
- 10. Middle East and Africa Virology Testing Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Virology Testing Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Virology Testing Market Outlook by Type
- 10.2.2 Middle East and Africa Virology Testing Market Outlook by Application
- 10.3 Middle East and Africa Virology Testing Market Outlook by Country
- 10.3.1 Saudi Arabia Virology Testing Market Outlook, 2021- 2032
- 10.3.2 The UAE Virology Testing Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Virology Testing Market Outlook, 2021- 2032
- 10.3.4 South Africa Virology Testing Market Outlook, 2021- 2032
- 10.3.5 Egypt Virology Testing Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Virology Testing Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Abbott Laboratories
- bioMérieux SA
- Bi-Rad Laboratories Inc
- Cepheid
- DiaSorin S.p.A.
- F. Hoffmann-La Roche AG
- Fujirebio Diagnostics Inc
- Hologic Inc
- QIAGEN N.V.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc
- Trinity Biotech plc
- Vircell S.L.
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
